Crizotinib

ATC L01ED01 · 11 markets · 35 records

Crizotinib 11 markets · 35 records Forms

US 5 records · 5 strengths

GB 5 records · 2 strengths

AU 5 records · 3 strengths

  • 250 mgcapsuleXalkoriXALKORI crizotinib 200 mg capsule blister pack also in US·GB·ES +5 unknown
  • 200 mgcapsuleXalkoriXALKORI crizotinib 200 mg capsule blister pack also in US·GB·ES +5 unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

ES 5 records · 5 strengths

CN 4 records · 2 strengths

CA 2 records · 2 strengths

SG 2 records · 2 strengths

TW 2 records · 2 strengths

  • 250 mgcapsuleXalkori截剋瘤膠囊250毫克 also in US·GB·AU +5
  • 200 mgcapsuleXalkori截剋瘤膠囊200毫克 also in US·GB·AU +5

HK 2 records · 1 strengths

    2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商

    FR 2 records · 2 strengths

    EU 1 records · 1 strengths

    EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

      1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

      Side-by-side table

      The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

      Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.